Currently holds a position at Sorrento Therapeutics Inc
Position | Company | Period |
---|---|---|
Chairman of the Board, President, Chief Executive Officer | Sorrento Therapeutics Inc | Aug. 1, 2017 - |
President, Chief Executive Officer, Director | Sorrento Therapeutics Inc | Sept. 22, 2012 - Aug. 1, 2017 |
Director | NantKwest Inc | Dec. 29, 2014 - Dec. 31, 2015 |
Interim Chief Executive Officer, Chief Scientific Officer, Director | Sorrento Therapeutics Inc | June 1, 2011 - Sept. 22, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-09-07 | 2022-09-07 |
Sorrento Therapeutics Inc
(SRNE)
|
B Purchase |
88,888
+1.9%
2.02179,349 USD |
88,888 +1.9% | 2.02 | 179,349 USD | |
2022-09-06 | 2022-09-06 |
Sorrento Therapeutics Inc
(SRNE)
|
B Purchase |
55,555
+1.2%
1.96108,882 USD |
55,555 +1.2% | 1.96 | 108,882 USD | |
2022-08-26 | 2022-08-26 |
Sorrento Therapeutics Inc
(SRNE)
|
B Purchase |
33,333
+1.6%
2.1170,333 USD |
33,333 +1.6% | 2.11 | 70,333 USD | |
2022-08-25 | 2022-08-25 |
Sorrento Therapeutics Inc
(SRNE)
|
B Purchase |
22,222
+1.1%
2.0645,768 USD |
22,222 +1.1% | 2.06 | 45,768 USD | |
2022-06-14 | 2022-06-14 |
Sorrento Therapeutics Inc
(SRNE)
|
B Purchase |
10,000
+0.5%
1.4013,999 USD |
10,000 +0.5% | 1.40 | 13,999 USD |